CRWD EQUITY Services-Prepackaged Software 2027 Quantitative Forecast

CrowdStrike Holdings, Inc. Class A Common Stock (CRWD) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$226.61
$-3.26 (-1.42%)
Market Close: Nov 13, 2026
1-Year Base Target
$251.99 +11.2%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$249.68 Bull $315
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$226.79 +0.1% Undervalued
Forward P/E 46.9x • PEG 5.91
AI Quant Stance
HOLD 54/100
RSI 42.6 • MACD Bearish • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for CRWD

AI Research Note

CRWD Price Forecast 2027: Our AI models project that CRWD stock will rise to approximately $251.99 by 2027. This represents a potential 11.2% growth from the current trading price of $226.61. The overall market sentiment for CRWD is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 4597.4, with its most recent quarterly earnings growing by 533.3%. CRWD shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 42.6, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 53.6/100
Composite Equity Stance
HOLD (Quant Score 54/100) — HOLD (+11.2% 1Y Target Upside)
Active Technical & Price Action Triggers
  • Moving averages converging - equilibrium state
  • MACD converging near zero line - potential energy building
  • Recent pattern: Belthold pattern detected
MACD Regime: Bearish
Volume Tape: Slight_Distribution

CRWD Trajectory & Forecast Curve

Projected price curve from spot ($226.61) across 30D–3Y horizons

Term Structure of Price Targets

Constant-multiple earnings trajectory model

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $228.64 +0.9%
90 Days 1 Quarter $232.96 +2.8%
6 Months Medium-Term $239.30 +5.6%
1 Year Base Model $251.99 +11.2%
2 Years EXTENDED $280.21 +23.7%
3 Years EXTENDED $311.60 +37.5%
Wall Street 12M Consensus Target: $249.68

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$314.99 +39.0%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$251.99 +11.2%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$176.39 -22.2%

Downside scenario if market headwinds or disappointing results

Reverse-DCF Implied Growth, Supply-Chain Moat & R&D Velocity

Proprietary deep-tech expectations gap, supply-chain bottleneck scoring & patent/filing velocity

Deep-Tech & Valuation Intelligence
Reverse-DCF: What's Priced In Priced Beyond Precedent
Market-Implied 5Y CAGR: 199.7%
Analyst Consensus CAGR: 17.2%
Expectation Gap (Implied vs Est): +182.5 pp
Universe: Technology Select Sector SPDR Fund (10%/yr hurdle rate)
R&D & Commercialization Velocity +1 R&D Citations (7d)
90D Commercialization Mentions: 55 disclosures
R&D Publications Tracked: 18 publications
Commercialization Themes:
ML Intrusion / Malware Detection (36) LLM / Agent Security (19)

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+0.1% Undervalued
Risk-Adjusted Consensus Fair Value: $226.79
Spot: $226.61

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) estimates CRWD fair value at $226.79 (+0.1% implied margin of safety), though its 5.91 PEG reflects a growth valuation premium.

PEG Ratio
5.91
Growth Premium
Implied Fair P/E
46.9x
Model Growth 11.2%
Trailing P/E
4597.40x
Forward P/E
46.87x
P/S Ratio (TTM)
43.62x
Rev Growth (YoY)
25.8%
EPS Growth (YoY)
533.3%
Market Cap
$235,372M
52-Week High
$286.99
52-Week Low
$85.68

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Slight_Distribution
Volume Tape: Slight_Distribution

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
42.6
Neutral
MACD Signal
Bearish
Primary Trend
Downtrend
Chaikin Money Flow
-0.066
Money Flow Index
42.5
200-Day SMA
$257.19

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 11/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on CRWD shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$52.25/sh
Profit at 1Y Target
$30.26/sh
Option Writer ROI
+57.9%
Applicable Structures
Covered Call (safest) • Naked Call (risky) • Credit Spread (defined risk)
Why Options Are Flagged for Premium Selling: The $230 Call (Sep 2027) requires CRWD to exceed $282.25 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $251.99, buying out-of-the-money calls carries negative expected value (Buyers lose 57.9% even if target hits. Premium is overpriced for 11.2% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
1Y Constant-PE Target
$251.99
+11.2% vs spot
Evaluated Call Strike
$230.00
Exp: Sep 17, 2027
Call Mark Premium
$52.25
23.1% of spot price
Call Buyer Breakeven
$282.25
Above 1Y base target
Delta / Implied Prob
62.4%
Option market odds
Contract Liquidity
222 OI
Vol: 2 • Nov 13

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Moderate Alert (Options Flow)
Flow Alert Score
74/100
Tape Classification
Moderate Alert (Options Flow)
Unusual Volume Score
69.9
Implied Volatility Spike
+86.8%
Derivative Tape Readout: Short-Term Derivative Tape: Moderate unusual activity. Monitor closely. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (CRWD 2027 Outlook)

What is the CRWD stock price prediction for 2027?

Based on our AI analysis, CRWD is predicted to reach $251.99 by 2027, representing a potential 11.2% increase from the current price of $226.61.

Is CRWD stock a good buy right now?

Our analysis rates CRWD as a HOLD (AI Quant Score 53.6/100) based on current technical and fundamental indicators. With a projected 11.2% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is CRWD 52-week high and low?

CRWD has a 52-week high of $286.99 and a 52-week low of $85.68. The stock is currently trading 21.0% below its 52-week high.

What is the technical analysis for CRWD?

CRWD is currently in a downtrend trend. The RSI of 42.6 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will CRWD stock be in 3 years?

Our long-term projection estimates CRWD could reach $311.60 by 2029, representing a 37.5% gain from current levels. Long-term predictions carry more uncertainty.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.